Tuma D J, Jennett R B, Sorrell M F
Biochim Biophys Acta. 1978 Nov 15;544(1):144-52. doi: 10.1016/0304-4165(78)90218-0.
The effects of phenobarbital on protein and glycoprotein synthesis and secretion were studied in rat liver slices. Phenobarbital (2 mM) decreased [14C]glucosamine and [14C]leucine incorporation into liver proteins and markedly inhibited their incorporation into medium (secretory) proteins. The inhibitory effect of phenobarbital was dose dependent and not reversible under the conditions of this study. In the presence of cycloheximide, an inhibitor of peptide synthesis, phenobarbital still inhibited the release of glycoproteins into the medium; however, the specific activity of liver glycoproteins was increased. The effects of phenobarbital on hepatic macromolecular secretion, independent of its effects on synthesis, were determined by prelabeling proteins in a liver slice system with either [14C]leucine or [14C]glucosamine. When phenobarbital was present, the secretion of these prelabeled proteins into the medium was inpaired. 12 h after intraperitoneal injections of phenobarbital, glycoprotein secretion was inhibited from liver slices prepared from the pretreated rats. This inhibition of secretion occurred even though protein synthesis was stimulated and intracellular glycosylations unaffected. The results of this study indicate that phenobarbital impairs the secretion of glycoproteins by the liver.
在大鼠肝切片中研究了苯巴比妥对蛋白质和糖蛋白合成及分泌的影响。苯巴比妥(2 mM)降低了[14C]葡糖胺和[14C]亮氨酸掺入肝脏蛋白质的量,并显著抑制它们掺入培养基(分泌性)蛋白质。在本研究条件下,苯巴比妥的抑制作用呈剂量依赖性且不可逆。在肽合成抑制剂环己酰亚胺存在的情况下,苯巴比妥仍抑制糖蛋白释放到培养基中;然而,肝脏糖蛋白的比活性增加。通过在肝切片系统中用[14C]亮氨酸或[14C]葡糖胺预标记蛋白质,确定了苯巴比妥对肝脏大分子分泌的影响,而与其对合成的影响无关。当存在苯巴比妥时,这些预标记蛋白质向培养基中的分泌受到损害。腹腔注射苯巴比妥12小时后,从预处理大鼠制备的肝切片中糖蛋白分泌受到抑制。即使蛋白质合成受到刺激且细胞内糖基化未受影响,这种分泌抑制仍会发生。本研究结果表明,苯巴比妥会损害肝脏糖蛋白的分泌。